On April 9-10, 2025, the 6th BIONNOVA Biopharma Innovators Forum & Exhibition was grandly held at the Zhangjiang Science Hall in Shanghai, bringing together over 10,000 innovators across the entire biopharmaceutical industry chain. As a key exhibitor, VKEY-BIO made a splendid appearance with its self-developed high-end detection kits and innovative technology solutions, joining industry peers to explore new opportunities in drug development.
Founded in 2019, VKEY-BIO is a high-tech enterprise focused on the R&D and production of premium domestic reagents. Backed by robust R&D capabilities and a rigorous quality management system, the company has obtained ISO9001 certification and earned multiple honors including "High-Tech Enterprise," "Innovative SME," and "Technology-Based SME."
We are committed to:
✔ Providing high-quality detection kits for drug development and life sciences to reduce costs and accelerate R&D processes;
✔ Developing innovative research tools to continuously enhance technical capabilities and deliver customized solutions for clients.
Exhibition Highlights: Cutting-Edge Products and Technologies
1. KeyTec® TR-FRET Kinase Assay Series
- Utilizes Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology combined with specific substrates and phospho-antibodies for highly sensitive and specific kinase activity detection.
- Covers various kinase types, including Cyclin-Dependent Kinases (CDKs) and Tyrosine Kinases (TKs).
- Features simple operation, stable results, and broad applications in drug screening and basic research.
2. KeyTec® 3D Cell Viability Assay
- Based on chemiluminescence technology, offering higher sensitivity and longer signal half-life.
- Provides reliable tools for tumor efficacy evaluation and organoid research.
3. KeyTec® Tool Box Products
-Protein-Protein Interaction (PPI) Analysis
-Nucleic Acid-Protein Interaction Studies
-Small Molecule Inhibitor Screening
VKEY-BIO's booth attracted numerous attendees for in-depth discussions. Our professional team provided detailed product demonstrations and application cases, offering tailored solutions for kinase inhibitor development and cellular function research.
Additionally, 100% of participating visitors received exquisite gifts, adding a delightful surprise to their exhibition experience.
The forum delved into hot topics such as antibody drugs, ADCs, cell and gene therapies, and small nucleic acid drugs. VKEY-BIO exchanged insights with experts on:
✔ Latest trends in kinase target research;
✔ The enabling role of cost-effective detection solutions in drug development;
✔ Innovation breakthroughs and industrialization prospects of domestic high-end reagents.
This exhibition further expanded VKEY-BIO's influence in the biopharmaceutical field. Moving forward, we will adhere to our philosophy of "Innovation-Driven, Quality First" to develop more high-quality domestic reagents and collaborate with industry partners to advance China's drug R&D endeavors!
English
